產(chǎn)品名稱：Acipimox 產(chǎn)品貨號：LKT A0833 產(chǎn)品規(guī)格：1g 5g 10g Acipimox Description Acipimox inhibits lipolysis in peripheral tissues and induces large reduction in circulating serum-free fatty acids. The mechanism of triglyceride lowering appears to be an increase of VLDL-Tg clearance. Specifications Cas No. 51037-30-0 Product ID A0833 Product Name Acipimox Chemical Name 5-Methylpyrazinecarboxylic acid 4-oxide Synonym Neotigason; Soriatane Formula Wt. 154.12 Melting Point 177oC-180oC Purity ≥98% Solubility Water 20 mg/mL Store Temp Ambient References Nuutinen, J. Minn, H., Bergmand, J. et al Br. J. Cancer 80:513-518 (1999). Hannah, J.S., Bodkin, NL., Paidi,, MS., et al. Acta Diabetol. 32:279-283 (1995).
滬公網(wǎng)安備 31011002002623號
